Umberto Benedetto1, Mario F Gaudino2, Arnaldo Dimagli1, Stephen Gerry3, Alastair Gray4, Belinda Lees5, Marcus Flather6, David P Taggart5. 1. Bristol Heart Institute, School of Clinical Sciences, University of Bristol, United Kingdom (U.B., A.D.). 2. Weill Cornell Medicine, New York-Presbyterian Hospital, New York (M.F.G.). 3. Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (S.G.), University of Oxford, United Kingdom. 4. Health Economics Research Centre, Nuffield Department of Population Health (A.G.), University of Oxford, United Kingdom. 5. Nuffield Department of Surgical Sciences, John Radcliffe Hospital (B.L., D.P.T.), University of Oxford, United Kingdom. 6. Research and Development Unit, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom (M.F.).
Abstract
BACKGROUND: Postoperative atrial fibrillation (pAF) after coronary artery bypass grafting is a common complication. Whether pAF is associated with an increased risk of cerebrovascular accident (CVA) remains uncertain. We investigated the association between pAF and long-term risk of CVA by performing a post hoc analysis of 10-year outcomes of the ART (Arterial Revascularization Trial). METHODS: For the present analysis, among patients enrolled in the ART (n=3102), we excluded those who did not undergo surgery (n=25), had a history of atrial fibrillation (n=45), or had no information on the incidence of pAF (n=9). The final population consisted of 3023 patients, of whom 734 (24.3%) developed pAF with the remaining 2289 maintaining sinus rhythm. Competing risk and Cox regression analyses were used to investigate the association between pAF and the risk of CVA. RESULTS: At 10 years, the cumulative incidence of CVA was 6.3% (4.6%-8.1%) versus 3.7% (2.9%-4.5%) in patients with pAF and sinus rhythm, respectively. pAF was an independent predictor of CVA at 10 years (hazard ratio, 1.53 [95% CI, 1.06-2.23]; P=0.025) even when CVAs that occurred during the index admission were excluded from the analysis (hazard ratio, 1.47 [95% 1.02-2.11]; P=0.04). CONCLUSIONS: Patients with pAF after coronary artery bypass grafting are at higher risk of CVA. These findings challenge the notion that pAF is a benign complication.
BACKGROUND:Postoperative atrial fibrillation (pAF) after coronary artery bypass grafting is a common complication. Whether pAF is associated with an increased risk of cerebrovascular accident (CVA) remains uncertain. We investigated the association between pAF and long-term risk of CVA by performing a post hoc analysis of 10-year outcomes of the ART (Arterial Revascularization Trial). METHODS: For the present analysis, among patients enrolled in the ART (n=3102), we excluded those who did not undergo surgery (n=25), had a history of atrial fibrillation (n=45), or had no information on the incidence of pAF (n=9). The final population consisted of 3023 patients, of whom 734 (24.3%) developed pAF with the remaining 2289 maintaining sinus rhythm. Competing risk and Cox regression analyses were used to investigate the association between pAF and the risk of CVA. RESULTS: At 10 years, the cumulative incidence of CVA was 6.3% (4.6%-8.1%) versus 3.7% (2.9%-4.5%) in patients with pAF and sinus rhythm, respectively. pAF was an independent predictor of CVA at 10 years (hazard ratio, 1.53 [95% CI, 1.06-2.23]; P=0.025) even when CVAs that occurred during the index admission were excluded from the analysis (hazard ratio, 1.47 [95% 1.02-2.11]; P=0.04). CONCLUSIONS:Patients with pAF after coronary artery bypass grafting are at higher risk of CVA. These findings challenge the notion that pAF is a benign complication.
Authors: Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy Journal: Circulation Date: 2014-03-28 Impact factor: 29.690
Authors: Ioanna Kosmidou; Shmuel Chen; A Pieter Kappetein; Patrick W Serruys; Bernard J Gersh; John D Puskas; David E Kandzari; David P Taggart; Marie-Claude Morice; Paweł E Buszman; Andrzej Bochenek; Erick Schampaert; Pierre Pagé; Joseph F Sabik; Thomas McAndrew; Björn Redfors; Ori Ben-Yehuda; Gregg W Stone Journal: J Am Coll Cardiol Date: 2018-02-20 Impact factor: 24.094
Authors: Joseph P Mathew; Manuel L Fontes; Iulia C Tudor; James Ramsay; Peter Duke; C David Mazer; Paul G Barash; Ping H Hsu; Dennis T Mangano Journal: JAMA Date: 2004-04-14 Impact factor: 56.272
Authors: Brian F Gage; Carl van Walraven; Lesly Pearce; Robert G Hart; Peter J Koudstaal; B S P Boode; Palle Petersen Journal: Circulation Date: 2004-10-11 Impact factor: 29.690
Authors: David P Taggart; Belinda Lees; Alastair Gray; Douglas G Altman; Marcus Flather; Keith Channon Journal: Trials Date: 2006-03-30 Impact factor: 2.279
Authors: Amar Taha; Susanne J Nielsen; Stefan Franzén; Mary Rezk; Anders Ahlsson; Leif Friberg; Staffan Björck; Anders Jeppsson; Lennart Bergfeldt Journal: J Am Heart Assoc Date: 2022-05-16 Impact factor: 6.106
Authors: Michael K Wang; Pascal B Meyre; Rachel Heo; P J Devereaux; Lauren Birchenough; Richard Whitlock; William F McIntyre; Yu Chiao Peter Chen; Muhammad Zain Ali; Fausto Biancari; Jawad Haider Butt; Jeff S Healey; Emilie P Belley-Côté; Andre Lamy; David Conen Journal: CJC Open Date: 2021-09-16
Authors: Constantin Mork; Simon Adrian Amacher; Brigitta Gahl; Luca Koechlin; Jules Miazza; Thibault Schaeffer; Lena Schmuelling; Jens Bremerich; Denis Berdajs; Nadine Cueni; Michael Kühne; Christian Mueller; Stefan Osswald; Oliver Reuthebuch; Ulrich Schurr; Christian Sticherling; Andrea Kopp Lugli; Stephan Marsch; Hans Pargger; Martin Siegemund; Friedrich Eckstein; Alexa Hollinger; David Santer Journal: ESC Heart Fail Date: 2022-04-19